Macrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi

PLoS Neglected Tropical Diseases

Volumn 2, Issue 6, 2008, Pages

  Ettinger, Nicholas A ^a,b   Wilson, Mary E ^a,b,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b The University of Iowa   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INITIATION FACTOR 2; INITIATION FACTOR 2C3; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; METALLOTHIONEIN I; MIXED LINEAGE LEUKEMIA PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 2; PEROXIREDOXIN; PHOSPHOGLYCERATE DEHYDROGENASE; SUMO 1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR 15; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 10B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CLUSTER ANALYSIS; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION PROFILING; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOMODULATION; INNATE IMMUNITY; LEISHMANIA CHAGASI; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MICROARRAY ANALYSIS; MICROENVIRONMENT; MONOCYTE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VISCERAL LEISHMANIASIS; WILD TYPE; ANIMAL; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LEISHMANIA; METABOLISM; MIDDLE AGED; PARASITOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEISHMANIA; MACROPHAGES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; YOUNG ADULT;

EID: 48949118074     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000252     Document Type: Article

References (47)

1. Wilson ME, Jeronimo SMB, Pearson RD (2005) Immunopathogenesis of infection with the visceralizing leishmania species. Microb Pathog 38(4): 147-160.
2. Jeronimo SMB, Teixeira MJ, Sousa A, Thielking P, Pearson RD, et al. (2000) Natural history of Leishmania (Leishmania) chagasi infection in northeastern Brazil: Long-term follow-up. Clin Infect Dis 30(3): 608-609.
3. Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD Jr. (1989) Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 83(3): 860-864.
4. Ghalib HW, Whittle JA, Kubin M, Hashim FA, el-Hassan AM, et al. (1995) IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 154(9): 4623-4629.
5. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, et al. (1996) Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 173(6): 1515-1518.
6. Karp CL, el-Safi SH, Wynn TA, Satti MM, Kordofani AM, et al. (1993) In vivo cytokine profiles in patients with kala-azar: marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91(4): 1644-1648.
7. Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, et al. (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92(1): 324-329.
8. Caldas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, et al. (2005) Balance of IL-10 and IFN-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis. BMC Infect Dis 5: 113. 10.1186/1471-2334-5-113.
9. + monocytes are hallmarks of active human visceral leishmaniasis due to Leishmania chagasi infection. Clin Exp Inummol 146(1): 124-132. 10.1111/ j.1365-2249.2006.03171.x.
10. Nylen S, Sacks D (2007) Interleukin- 10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28(9): 378-384. 10.1016/ j.it.2007.07.004.
11. Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, et al. (1991) Soluble IL-2 recepto as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147(1): 281-284.
12. Arta AM, D'Oliveira, Correa J, Atta ML, Almeida RP, et al. (1998) Antileishmanial IgE antibodies: A marker of active disease in visceral leishmaniasis. Am J Trop Med Hyg 59(3): 426-430.
13. Nascimento ET, Gantt KR, Pontes NN, Bacclar O, Luz VE, et al. (2002) TGF-β in acute visceral leishmaniasis. Am J Trop Med Hyg 67(2): 262.
14. Buates S, Matlashewski G (2001) General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol 166(5): 3416-3422.
15. Bertholet S, Dickensheets HL, Sheikh F, Gam AA, Donnelly RP, et al. (2003) Leishmania donovavi-induced expression of suppressor of cytokine signaling 3 in human macrophages: A novel mechanism for intracellular parasite suppression of activation. Infect Immun 71(4): 2095-2101.
16. Misra S, Tripathi MK, Chaudhuri G (2005) Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages. J Biol Chem 280(32): 29364-29373. 10.1074/jbc.M504162200.
17. Dogra N, Warburton C, McMaster WR (2007) Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective. Infect Immun 75(7): 3506-3515.
18. Berens RL, Brun & Krassner SM (1976) A simple monophasic medium for axenic culture of hemoflagellates. J Parasitol 62(3): 360-365.
19. Jeronimo SMB, Duggal P, Braz RF, Cheng C, Monteiro GR, et al. (2004) An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in northeast Brazil. Scand J Infect Dis 36(6-7): 443-449.
20. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5(10): R80. 10.1186/gb-2004-5-10-r80.
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2): 249-264. 10.1093/biostatistics/4.2.249.
22. Wu Z, Irizarry RA, Gentleman RC, Martinez-Murillo F, Spencer F (2004) A model-based background adjustment for oligonucleotide expression arrays. J Am Star Assoc 99(468): 909-917.
23. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: A simple, yet powerfiA new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573(1-3): 83-92. 10.1016/ j.febslet.2004.07.055.
24. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: A Bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22(22): 2825-2827. bt1476 [pii]; 10.1093/bioinformatics/bt1476 [doi].
25. Storey JD, Tibshirani R (2003) Statistical significancc for genomewide studies. Proc Natl Acad Sci U S A 100(16): 9440-9445. 10.1073/ pnas.1530509100.
26. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4(5): P3.
27. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43): 15545-15550. 0506580102 [pii]; 10.1073/pnas.0506580102 [doi].
28. )) method. Methods 25(4): 402-408. 10.1006/meth.2001.1262.
29. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, et al. (2002) Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A 99(3). 1503-1308. 10.1073/ pnas.022649799.
30. Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K, et al. (2003) Short-interfering-RNA-mediated gene silencing in mammalian cells requires dicer and eIF2C translation initiation factors. Curr Biol 13(1): 41-46.
31. Manevich Y, Fisher AB (2005) Peroxiredoxin 6, a 1-cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 38(11): 1422-1432. 10.1016/j.freeradbiomed.2005.02.011.
32. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73(2): 209-212.
33. + phenotype from tonsils, cord and adult peripheral blood. Clin Exp Immunol 138(3): 460-465. 10.1111/ j.1365-2249.2004.02651.x.
34. Coyle P, Philcox JC, Carey LC, Rofe AM (2002) Metallothionein: The multipurpose protein. Cell Mol Life Sci 59(4): 627-647.
35. Brocke-Heidrich K, Kretzschmar AK, Pfeifer G, Henze C, Loffler D, et al. (2004) Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a bcl-2 family-independent survival pathway closely associated with Stat3 activation. Blood 103(1): 242-251. 10.1182/blood-2003-04-1048.
36. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2(11): 845-858.
37. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE (1998) The importance of TGF-β in murine visceral leishmaniasis. J Immunol 161(11): 6148-6155.
38. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β. Annu Rev Immunol 16: 137-161. 10.1146/ annurev.immunol.16.1.137.
39. Rodriguez NE, Chang HK, Wilson ME (2004) Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun 72(4): 2111-2122.
40. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, et al. (2003) Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102(2): 672-681. 10.1182/ blood-2002-10-3232.
41. Rogers KA, Titus RG (2004) The human cytokine response to Leishmania major early after exposure to the parasite in vitro. J Parasitol 90(3): 557-563.
42. Reiner NE, Ng W, Wilson CB, McMaster WR, Burchett SK (1990) Modulation of in vitro monocyte cytokine responses to Leishmania donovani: Interferon-gamma prevents parasite-induced inhibition of interleukin-1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin-1. J Clin Invest 85(6): 1914-1924.
43. Blanchette J, Racette N, Faure R, Siminovitch KA, Olivier M (1999) Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur J Immunol 29(11): 3737-3744.
44. Streit JA, Donelson JE, Agey MW, Wilson ME (1996) Developmental changes in the expression of Leishmania chagasi gp63 and heat shock protein in a human macrophage cell line. Infect Immun 64(5): 1810-1818.
45. Rodriguez NE, Gaur U, Wilson ME (2006) Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol 8(7): 1106-1120. 10.1111/j.1462-5822.2006.00695.x.
46. Edwards JP, Zhang X, Frauwirth KA, Mosser DM (2006) Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80(6): 1298-1307. 10.1189/jlb.0406249.
47. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187(6): 875-883.